BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11106260)

  • 1. Prostate cancer radiosensitization in vivo with adenovirus-mediated p53 gene therapy.
    Cowen D; Salem N; Ashoori F; Meyn R; Meistrich ML; Roth JA; Pollack A
    Clin Cancer Res; 2000 Nov; 6(11):4402-8. PubMed ID: 11106260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenoviral-mediated p53 transgene expression sensitizes both wild-type and null p53 prostate cancer cells in vitro to radiation.
    Colletier PJ; Ashoori F; Cowen D; Meyn RE; Tofilon P; Meistrich ME; Pollack A
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1507-12. PubMed ID: 11121656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic adenovirus CG7870 in combination with radiation demonstrates synergistic enhancements of antitumor efficacy without loss of specificity.
    Dilley J; Reddy S; Ko D; Nguyen N; Rojas G; Working P; Yu DC
    Cancer Gene Ther; 2005 Aug; 12(8):715-22. PubMed ID: 15832172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenoviral-mediated wild-type p53 gene expression sensitizes colorectal cancer cells to ionizing radiation.
    Spitz FR; Nguyen D; Skibber JM; Meyn RE; Cristiano RJ; Roth JA
    Clin Cancer Res; 1996 Oct; 2(10):1665-71. PubMed ID: 9816114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells.
    Hsieh CL; Gardner TA; Miao L; Balian G; Chung LW
    Cancer Gene Ther; 2004 Feb; 11(2):148-55. PubMed ID: 14695756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The suppression of human prostate tumor growth in mice by the intratumoral injection of a slow-release polymeric paste formulation of paclitaxel.
    Jackson JK; Gleave ME; Yago V; Beraldi E; Hunter WL; Burt HM
    Cancer Res; 2000 Aug; 60(15):4146-51. PubMed ID: 10945622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The addition of adenovirus type 5 region E3 enables calydon virus 787 to eliminate distant prostate tumor xenografts.
    Yu DC; Chen Y; Seng M; Dilley J; Henderson DR
    Cancer Res; 1999 Sep; 59(17):4200-3. PubMed ID: 10485454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription-targeted gene therapy for androgen-independent prostate cancer.
    Martiniello-Wilks R; Tsatralis T; Russell P; Brookes DE; Zandvliet D; Lockett LJ; Both GW; Molloy PL; Russell PJ
    Cancer Gene Ther; 2002 May; 9(5):443-52. PubMed ID: 11961667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated levels of prostate-specific antigen (PSA) in prostate cancer cells expressing mutant p53 is associated with tumor metastasis.
    Downing S; Bumak C; Nixdorf S; Ow K; Russell P; Jackson P
    Mol Carcinog; 2003 Nov; 38(3):130-40. PubMed ID: 14587098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CV706, a prostate cancer-specific adenovirus variant, in combination with radiotherapy produces synergistic antitumor efficacy without increasing toxicity.
    Chen Y; DeWeese T; Dilley J; Zhang Y; Li Y; Ramesh N; Lee J; Pennathur-Das R; Radzyminski J; Wypych J; Brignetti D; Scott S; Stephens J; Karpf DB; Henderson DR; Yu DC
    Cancer Res; 2001 Jul; 61(14):5453-60. PubMed ID: 11454691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
    Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
    Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
    Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
    Igawa T; Lin FF; Rao P; Lin MF
    Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated p53 gene therapy inhibits human sarcoma tumorigenicity.
    Milas M; Yu D; Lang A; Ge T; Feig B; El-Naggar AK; Pollock RE
    Cancer Gene Ther; 2000 Mar; 7(3):422-9. PubMed ID: 10766348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer.
    Spitz FR; Nguyen D; Skibber JM; Cusack J; Roth JA; Cristiano RJ
    Anticancer Res; 1996; 16(6B):3415-22. PubMed ID: 9042200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumorigenic effect of a K-ras ribozyme against human lung cancer cell line heterotransplants in nude mice.
    Zhang YA; Nemunaitis J; Scanlon KJ; Tong AW
    Gene Ther; 2000 Dec; 7(23):2041-50. PubMed ID: 11175317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor.
    Zhang Y; Ma Y; Lu HP; Gao JH; Liang CS; Liu CZ; Zou JT; Wang HQ
    Chin Med J (Engl); 2008 Nov; 121(22):2284-9. PubMed ID: 19080333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus mediated cytosine deaminase gene transduction and 5-fluorocytosine therapy sensitizes mouse prostate cancer cells to irradiation.
    Anello R; Cohen S; Atkinson G; Hall SJ
    J Urol; 2000 Dec; 164(6):2173-7. PubMed ID: 11061950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of anti-gene and antisense therapeutics on human prostate cancer xenograft in nude mice].
    Zhang Y; Ma Y; Lu HP; Zhou XF; Xie Y; Gao JH; Liang CS
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2073-6. PubMed ID: 19080439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adenovirus-mediated p53 gene therapy of human laryngeal cancer].
    Wang Q; Han D; Wang W
    Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):418-21. PubMed ID: 10920932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.